Welcome to Glycotope

Targeting tumor-specific glycosylation patterns to enable advanced therapies

We are Glycotope

We are dedicated to improving the lives of cancer patients by enabling treatment options that go beyond today’s standard of care.

With exceptional experience in glycobiology and therapeutic antibody development, our mission is to develop advanced biologics that facilitate novel approaches to cancer therapies.

Setting new standards of tumor-specificity in antibody therapeutics

About Us

Learn More about Glycotope and our Leadership Team


Our proprietary technology platform enables the development of antibodies with unrivaled tumor-specificity


Our pipeline of antibody therapeutics includes in-house and partnered pre-clinical programs


We aim to continuously expand our collaborations with industry partners and academic centers to further exploit the unique potential of our technology